The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo. (Q40568156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Rogelio Hernández-Pando

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

Mario Alberto Flores-Valdez

21 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Carolina Guapillo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Jorge Barrios-Payán

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Dulce Mata-Espinosa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Michel de Jesús Aceves-Sánchez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Brenda Marquina-Castillo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

English

0 references

publication date

18 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

4763-4770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Tuberculosis vaccine development: Shifting focus amid increasing development challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Current efforts and future prospects in the development of live mycobacteria as vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Vaccines Directed Against Microorganisms or Their Products Present During Biofilm Lifestyle: Can We Make a Translation as a Broad Biological Model to Tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Roles of cyclic diguanylate in the regulation of bacterial pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

The Cyclic Di-GMP Phosphodiesterase Gene Rv1357c/BCG1419c Affects BCG Pellicle Production and In Vivo Maintenance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

How "humane" is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Persistent and dormant tubercle bacilli and latent tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Macrophages and control of granulomatous inflammation in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

The immunological aspects of latency in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

The PGRS domain of Mycobacterium tuberculosis PE_PGRS Rv1759c antigen is an efficient subunit vaccine to prevent reactivation in a murine model of chronic tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

BCG-induced protection: effects on innate immune memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Binding of bacterial secondary messenger molecule c di-GMP is a STING operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Roles of PE_PGRS family in Mycobacterium tuberculosis pathogenesis and novel measures against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Expression, purification, and characterization of the Mycobacterium tuberculosis acyl carrier protein, AcpM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.035

10.1016/J.VACCINE.2016.08.035

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27546876%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference